2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trialEmiel A De Jaeghere,Sandra Tuyaerts,An MT van Nuffel, Ann Belmans,Kris Bogaerts,Regina Baiden-Amissah,Peter Vuylsteke,Stéphanie Henry,Xuan Bich Trinh,Peter A van Dam,Sandrine Aspeslagh,Alex de Caluwé,Eline Naert,Diether Lambrechts,An Hendrix,Olivier de Wever,Koen K van de Vijver,Frédéric Amant,Katrien Vandecasteele,Hannelore G DenysMiscellaneous（2022）引用 0|浏览9暂无评分关键词uterine cancer,chemotherapy-pretreatedAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
